What’s Next: Deals and IPOs
What companies are candidates for acquisition? Which unicorns will go public? Where will private money flow? Let’s find out.
Peter Orszag, Head of North American M&A, Vice Chairman of Investment Banking, Global Co-Head of Health Care, Lazard Frères & Co.
Jorge Conde, General Partner, Andreessen Horowitz
Ali Satvat, Member, Private Equity, KKR
Moderator: David Faber, Co-anchor, “Squawk on the Street,” CNBC
Genetics, CRISPR and Medical Ethics
It’s perhaps the most promising medical technology in a generation, but how can we ensure its responsible use?
Paul Dabrowski, CEO, Synthego
Dr. Samarth Kulkarni, CEO, CRISPR Therapeutics
Moderator: Meg Tirrell, Biotech and pharma reporter, CNBC
Transformation: Data, A.I. and Health Care
A rapid-fire discussion of the ways drug development, diagnostics and delivery are being reinvented with the use of big data analysis and artificial intelligence.
Daphne Koller, Founder and CEO, insitro
Dr. Jennifer Schneider, President, Livongo
Peter Lee, AI Research, Microsoft Health
Dr. Farzad Mostashari, Co-founder and CEO, Aledade
Moderator: Christina Farr, Technology and Health Reporter, CNBC.com
Defining the Future of US Health Care
Groundbreaking technology, backbreaking costs, policy battles, incredible cures. A panel of leading health-care influencers discuss what they see coming next.
Dr. Ashish Jha, Global Health Director, Harvard University
Bob Sheehy, Co-founder and CEO, Bright Health; Fmr CEO, UnitedHealthcare
Andy Slavitt, General Partner, Town Hall Ventures; Fmr Commissioner, CMS
Moderator: To be announced
The View from New Brunswick
What the future health-care landscape looks like from atop one of the world’s biggest and most admired health-care companies.
Alex Gorsky, Chairman and CEO, Johnson & Johnson
Interviewer: Meg Tirrell, Biotech and pharma reporter, CNBC